68 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Downtrend
Article Searches
Bristol-Myers' Shareholders Vote for Celgene Acquisition http://www.zacks.com/stock/news/381001/bristol-myers-shareholders-vote-for-celgene-acquisition?cid=CS-ZC-FT-381001 Apr 15, 2019 - Bristol-Myers' (BMY) gets a green signal from a majority of its shareholders for the merger with Celgene Corporation.
J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View http://www.zacks.com/stock/news/382057/jj-jnj-beats-on-q1-earnings-ups-2019-sales-growth-view?cid=CS-ZC-FT-382057 Apr 16, 2019 - J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2019 and raises 2019 guidance for operational sales and adjusted operational EPS growth. Shares up in pre-market trading.
Top Analyst Reports for Wells Fargo, UnitedHealth & Merck http://www.zacks.com/research-daily/382658/top-analyst-reports-for-wells-fargo-unitedhealth-merck?cid=CS-ZC-FT-382658 Apr 17, 2019 - Top Analyst Reports for Wells Fargo, UnitedHealth & Merck
Kidney-Cancer Market: Good for Patients, Hard for Investors https://www.fool.com/investing/2019/04/23/kidney-cancer-market-good-for-patients-hard-for-in.aspx?source=iedfolrf0000001 Apr 23, 2019 - Drugmakers battle for patients.
What's in the Cards for AstraZeneca (AZN) in Q1 Earnings? http://www.zacks.com/stock/news/392203/whats-in-the-cards-for-astrazeneca-azn-in-q1-earnings?cid=CS-ZC-FT-392203 Apr 23, 2019 - AstraZeneca (AZN) will report first-quarter results on Apr 26. New drugs likely to drive sales.
AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales http://www.zacks.com/stock/news/404479/astrazenecas-azn-q1-earnings-beat-new-drugs-drive-sales?cid=CS-ZC-FT-404479 Apr 26, 2019 - AstraZeneca (AZN) beats earnings and sales estimates in the first quarter. New drugs, especially cancer drugs, drive revenues.
Merck (MRK) Tops on Q1 Earnings & Sales, Stock Up http://www.zacks.com/stock/news/405495/merck-mrk-tops-on-q1-earnings-sales-stock-up?cid=CS-ZC-FT-405495 Apr 30, 2019 - Merck (MRK) beats estimates for earnings as well as sales in first-quarter 2019. Stock is up in pre-market trading.
Merck & Co Inc. (MRK) CEO Ken Frazier on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4258153-merck-and-co-inc-mrk-ceo-ken-frazier-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare Apr 30, 2019 - Merck & Co Inc. (NYSE:MRK) Q1 2018 Earnings Conference Call April 30, 2019 8:00 AM ET Company Participants Teri Loxam - SVP, Investor Relations and Global Communications Ken Frazier - Chairman and
Company News For May 1, 2019 http://www.zacks.com/stock/news/406426/company-news-for-may-1-2019?cid=CS-ZC--406426 May 01, 2019 - Companies in the news are: GE, GM, MRK and MA
Are You Looking for a High-Growth Dividend Stock? Merck (MRK) Could Be a Great Choice http://www.zacks.com/stock/news/407489/are-you-looking-for-a-high-growth-dividend-stock-merck-mrk-could-be-a-great-choice?cid=CS-ZC-FT-407489 May 02, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.

Pages: 1234567

<<<Page 6